Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Abhinav Jain is Director at Xtant Medical Holdings. OQRO lists 5 transactions filed with the SEC under this name, the latest on Aug 18, 2026, each linked to the official Form 4.
Director
Disclosures on record
5
Companies involved
3
Xtant Medical HoldingsXTNT
2 disclosures · Nov 2025 – Aug 2026
Aug 15, 2026216Kdisclosed Aug 18
DetailsOfficial recordNov 15, 2025158Kdisclosed Nov 18
DetailsOfficial recordAytu BiopharmaAYTU
Jul 28, 202610Kdisclosed Jul 30
DetailsOfficial recordTalpheraTLPH
2 disclosures · Jun 2026
Jun 22, 20265,100disclosed Jun 24
DetailsOfficial recordJun 22, 202631Kdisclosed Jun 24
DetailsOfficial recordAs of the latest filing on , Abhinav Jain reported holding 29,500 shares of Aytu Biopharma (AYTU), worth about $78K at the last close of $3 (Nov 17, 2026). Holdings are also on file at Xtant Medical Holdings (XTNT), Talphera (TLPH); together they are worth about $165K.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Aytu Biopharma AYTU | 29,500 | 30K direct | $3 | $78K | Jul 28, 2026 |
| Xtant Medical Holdings XTNT | 373,745 | 374K direct | $0 | $77K | Aug 15, 2026 |
| Talphera TLPH | 12,412 | 12K direct | $1 | $9.9K | Jun 22, 2026 |
Is this Abhinav Jain’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
On the latest SEC Form 4, dated Jul 28, 2026, Abhinav Jain reported holding 29,500 shares of Aytu Biopharma (AYTU). At the last close of $3 on Nov 17, 2026, that is about $78K. This is the stake disclosed in filings, not a net worth.